A Phase 4 interventional study of Dexamethasone in Tinnitus, sponsored by Combined Military Hospital, Pakistan. Status unknown at 1 site in Pakistan. Open to participants aged 19 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-03-15.
Sponsored by Combined Military Hospital, Pakistan · Phase 4, Interventional, and Treatment
Objective: To determine the effectiveness of Intratympanic dexamethasone with lignocaine in control of idiopathic tinnitus.
Methodology: 264 consenting patients with idiopathic unilateral tinnitus presenting at ENT Department were assessed for tinnitus severity using Modified Tinnitus Handicap Inventory and the scores recorded and subsequently administered intratympanically 2.0 ml (milliliter's) of dexamethasone and lignocaine (1.5 ml dexamethasone + 0.5 ml 1% lignocaine). The dose was repeated twice at weekly intervals. All patients were re assessed on Modified Tinnitus Handicap Inventory two weeks after third Intratympanic administration.
444 studies on the registry are indexed under Tinnitus; 98 are open to participants now.
This study's planned enrollment of 264 is above the median of 60 across 368 interventional studies indexed under Tinnitus.
Browse Tinnitus studies →Combined Military Hospital, Pakistan is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Dexamethasone
Steroids and analgesics
Also known as: Lignocaine
Tinnitus relief
Tinnitus relief ascertained by Modified Tinnitus Handicap Inventory
Time frame: 2 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dexamethasone
Combined Military Hospital, Pakistan